Ophthalmic Laser Devices Sales

Ophthalmic Laser Devices Sales Market Outlook

The global ophthalmic laser devices market is projected to reach approximately USD 5.4 billion by 2035, growing at a CAGR of around 5.4% from 2025 to 2035. This growth is driven by the rising incidence of eye disorders, including cataracts and diabetic retinopathy, alongside an increasing aging population. Moreover, advancements in laser technology and a growing preference for minimally invasive procedures are further propelling the market forward. The expansion of healthcare infrastructure and the adoption of innovative medical technologies in emerging economies also provide an impetus for the growth of ophthalmic laser devices. Alongside these factors, heightened awareness of eye care and vision correction is anticipated to significantly contribute to the overall market development.

Growth Factor of the Market

The market for ophthalmic laser devices is experiencing robust growth due to several crucial factors. One of the primary growth drivers is the increasing prevalence of vision-related disorders stemming from lifestyle changes, such as increased screen time and poor dietary choices. Additionally, the expanding geriatric population is further contributing to the rise in eye-related issues, thus boosting the demand for effective surgical interventions. The introduction of advanced laser technologies that minimize recovery time and enhance surgical precision also plays a vital role in promoting the adoption of these devices. Furthermore, the growing trend of outpatient procedures helps to enhance patient convenience, making ophthalmic laser treatments more accessible. Health insurance coverage for laser surgeries is gradually improving, thereby encouraging more patients to opt for these advanced treatment methods.

Key Highlights of the Market

• The global ophthalmic laser devices market is projected to reach USD 5.4 billion by 2035.
• Growing aging population significantly contributes to increased prevalence of eye disorders.
• Advancements in laser technology are enhancing the effectiveness of treatment procedures.
• Minimally invasive nature of laser surgeries is attracting more patients.
• Improved health insurance coverage is making ophthalmic laser treatments more accessible.

By Product Type

Excimer Lasers:

Excimer lasers are extensively utilized in the ophthalmic sector, particularly for refractive surgeries like LASIK. This technology operates by delivering ultraviolet light to reshape the cornea, enabling patients to achieve improved vision without glasses or contact lenses. The precision offered by excimer lasers significantly reduces the risk of complications and enhances the overall surgical experience for patients. As a result, there is a growing demand for excimer lasers in hospitals and specialized ophthalmology clinics. Innovations in excimer laser technology are continuously being developed, contributing to the segment's growth. Additionally, the rising awareness about vision correction procedures is further propelling the adoption of excimer lasers in the ophthalmic market.

Femtosecond Lasers:

Femtosecond lasers represent a breakthrough in ocular surgery, enabling high-precision cuts and reducing dependency on surgical blades. This laser technology is predominantly used in refractive surgeries, cataract procedures, and corneal transplants. The ability to perform intricate tasks with enhanced accuracy minimizes the risk of complications and accelerates patient recovery times. With the increasing emphasis on patient safety and outcomes, femtosecond lasers are witnessing a surge in adoption among healthcare providers. Their use in complicated procedures has positioned them as a critical component of modern ophthalmic surgeries, which is likely to bolster market growth in the coming years.

Nd:YAG Lasers:

Nd:YAG lasers are widely employed in treating a variety of eye conditions, including posterior capsulotomy and laser iridotomy. Their versatility and effectiveness in managing common ophthalmic issues make them essential devices in eye care facilities. Nd:YAG lasers are known for their ability to penetrate tissue effectively, allowing for precise treatment of specific areas without damaging surrounding tissues. As the demand for effective eye treatments rises, the adoption of Nd:YAG lasers is expected to increase significantly. Additionally, ongoing research and development efforts are aimed at enhancing the performance of these lasers, adding to their appeal within the ophthalmic market.

Diode Lasers:

Diode lasers are increasingly gaining popularity for their compact size and versatility in various ophthalmic applications. They are commonly used for treating diabetic retinopathy and glaucoma, where accurate targeting of retinal tissue is crucial. The continuous advancement in diode laser technology, coupled with their affordability, makes them an attractive option for many healthcare providers. As the incidence of chronic eye diseases rises, the demand for diode lasers is expected to grow, further solidifying their position in the ophthalmic laser devices market. Their effectiveness in outpatient settings also enhances their market appeal.

Others:

This category encompasses various other types of lasers utilized in ophthalmic procedures, including Argon lasers and KTP lasers. These lasers serve specialized functions in treating diverse eye conditions, offering healthcare professionals an array of treatment options. Despite being less predominant than the previously mentioned laser types, they still play a significant role in specific surgical scenarios where targeted treatments are required. The continuous evolution of laser technology ensures that these devices remain relevant in the ever-changing landscape of ophthalmic treatments, further supporting the overall market growth.

By Application

Refractive Error Correction:

Refractive error correction is one of the dominant applications of ophthalmic laser devices, primarily addressing conditions such as myopia, hyperopia, and astigmatism. The use of lasers, particularly excimer and femtosecond lasers, has revolutionized how these vision issues are treated, allowing for accurate reshaping of the cornea to enhance visual acuity. The increasing prevalence of refractive errors, coupled with the rising propensity of individuals towards corrective surgeries as opposed to traditional eyewear, is significantly driving this segment. As technology improves and procedures become more accessible, the refractive error correction market is expected to witness substantial growth over the coming years.

Cataract Surgery:

Cataract surgery is another significant application of ophthalmic lasers, with femtosecond lasers increasingly being utilized for precision lens removal and implantation. The growth of this segment is propelled by the escalating incidence of cataracts due to the aging population, necessitating effective surgical options to restore vision. Femtosecond lasers enhance the accuracy of cataract procedures while reducing recovery time, thus improving overall patient outcomes and satisfaction. As the medical community continues to recognize the advantages of laser-assisted surgery over traditional methods, the cataract surgery segment is poised for steady growth in the ophthalmic laser devices market.

Diabetic Retinopathy Treatment:

Diabetic retinopathy treatment significantly leverages various ophthalmic lasers for effective management of diabetic eye diseases. This application focuses on reducing the risk of vision loss in diabetic patients through procedures like laser photocoagulation. With the increasing prevalence of diabetes globally, the demand for effective treatment options for diabetic retinopathy is on the rise. The ability of lasers to deliver precise interventions while minimizing side effects contributes to their popularity in treating this condition. As awareness of diabetic retinopathy and its implications on vision continues to grow, this segment is expected to expand rapidly.

Glaucoma Treatment:

Ophthalmic lasers play a vital role in the management of glaucoma, a leading cause of blindness worldwide. Technologies such as selective laser trabeculoplasty (SLT) have emerged as effective treatments to lower eye pressure and protect optic nerve health. The increasing incidence of glaucoma, combined with the advantages of laser treatments over traditional methods, is propelling the demand for ophthalmic laser devices in this area. Enhanced patient education regarding the importance of early detection and treatment will further bolster the growth of this segment, making laser therapy a preferred choice among healthcare professionals.

Others:

This category includes various applications of ophthalmic lasers for treating conditions such as retinal tears and age-related macular degeneration. Although less prevalent than refractive error correction, cataract surgery, and diabetic retinopathy treatment, these applications still make a significant contribution to the overall market. The diverse range of treatment options provided by ophthalmic lasers allows healthcare providers to address a wide array of ocular conditions effectively. Ongoing advancements in laser technology will continue to support the growth of this segment, ensuring that patients receive comprehensive care for their eye health needs.

By End User

Hospitals:

Hospitals are among the primary end users of ophthalmic laser devices, housing advanced surgical units equipped with state-of-the-art laser technologies. These institutions often cater to a broad patient base, offering specialized services for various eye conditions. The convenience of having multiple treatment options under one roof, alongside the availability of skilled ophthalmologists, makes hospitals a preferred choice for patients seeking laser treatments. As patient awareness regarding eye health increases, hospitals are expected to invest in the latest laser technologies to enhance their surgical offerings and improve patient outcomes, contributing to the growth of this segment.

Ophthalmic Clinics:

Ophthalmic clinics are specialized healthcare facilities dedicated exclusively to eye care and treatment. The demand for ophthalmic laser devices in these clinics is on the rise due to the increasing number of patients seeking corrective procedures for refractive errors and cataracts. These clinics often provide a more personalized approach to care, allowing patients to access advanced laser treatments without the complexities of hospital settings. As the number of outpatient surgical procedures rises, ophthalmic clinics are likely to see significant growth in the adoption of laser devices, further promoting their position within the ophthalmic market.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are gaining prominence as efficient alternatives to traditional hospital settings for eye surgeries. These centers focus on providing same-day surgical services, allowing patients to undergo procedures and return home the same day. The rising preference for outpatient procedures due to their convenience, affordability, and reduced recovery times has spurred the growth of ASCs. The utilization of ophthalmic laser devices within these centers continues to increase as more patients opt for minimally invasive surgeries, reinforcing the segment's contribution to the overall market.

Others:

This category encompasses other healthcare providers offering ophthalmic laser services, including specialty hospitals and mobile surgical units. While these entities may not be as widely recognized as hospitals or ophthalmic clinics, they play an essential role in expanding access to ophthalmic laser treatments. Their unique offerings can cater to underserved populations and enhance the availability of eye care in remote areas. As the demand for eye care continues to grow, these alternative end users are anticipated to contribute positively to the overall market's expansion.

By Technology

Photodisruption:

Photodisruption technology is a critical innovation in ophthalmic lasers, primarily used in procedures like LASIK and cataract surgeries. This technology employs high-energy laser pulses to create precise disruptions in tissue, allowing for accurate reshaping of the cornea and lens. The advantages of photodisruption, such as minimal thermal damage and quick recovery times, make it a preferred method among ophthalmologists. As patient safety and surgical outcomes remain a top priority, the demand for photodisruption technologies is expected to grow, further enhancing the ophthalmic laser devices market.

Photocoagulation:

Photocoagulation technology is widely utilized for treating various retinal diseases, including diabetic retinopathy and age-related macular degeneration. This technique employs laser energy to create controlled burns on the retina, effectively sealing leaking blood vessels and preventing further vision loss. The increasing prevalence of retinal diseases is driving the adoption of photocoagulation techniques among healthcare professionals. As technology advances, the efficacy and precision of photocoagulation procedures are anticipated to improve, further supporting the growth of this segment in the ophthalmic laser devices market.

Selective Laser Trabeculoplasty:

Selective laser trabeculoplasty (SLT) is a cutting-edge technology used in the treatment of glaucoma. By targeting specific cells within the eye, SLT effectively lowers intraocular pressure while preserving surrounding tissues. This minimally invasive approach offers patients a safe and effective alternative to traditional glaucoma treatments, making it increasingly popular among ophthalmic practitioners. As awareness regarding glaucoma management grows, the adoption of SLT is expected to rise significantly. The positive outcomes associated with SLT treatments are likely to strengthen this segment’s position in the ophthalmic laser devices market.

Photorefractive Keratectomy:

Photorefractive keratectomy (PRK) is a laser surgery technique utilized for correcting refractive errors. This method involves the removal of the epithelial layer of the cornea, followed by laser reshaping of the underlying tissue. PRK is an excellent option for patients who may not be suitable candidates for LASIK surgeries. The growing preference for PRK among patients with specific corneal characteristics is gradually increasing the demand for this technology. Continuous advancements in PRK techniques, resulting in improved outcomes and shorter recovery times, are further promoting its adoption in the ophthalmic laser devices market.

Others:

This category includes various emerging technologies in ophthalmic lasers, such as femtosecond laser technology and continuous wave lasers. These technologies are being developed to expand the options available for laser-assisted eye surgeries, catering to a broader range of patient needs. As research and innovations in laser technology continue to evolve, the market for these alternative technologies is expected to grow. The ongoing advancements will enhance surgical precision, minimize risks, and shorten recovery times, thereby fostering an environment conducive to market expansion.

By Region

The North American ophthalmic laser devices market holds a significant share, valued at approximately USD 2 billion in 2025. The region's dominance can be attributed to advanced healthcare infrastructure, high awareness levels regarding eye health, and the presence of key market players. As the aging population in the U.S. and Canada continues to rise, the demand for ophthalmic laser treatments will likely increase significantly. Furthermore, technological advancements and innovations in laser systems are expected to contribute to the steady growth of the North American market over the forecast period, with a projected CAGR of 5.6% through 2035.

Europe is another key player in the ophthalmic laser devices market, estimated to reach around USD 1.2 billion by 2025. This growth is fueled by the increasing prevalence of eye disorders, the aging population, and advancements in laser technology across the region. As European countries continue to focus on improving healthcare services and adopting cutting-edge medical technologies, the ophthalmic laser devices market is poised for significant expansion. Countries such as Germany, France, and the UK are leading in the adoption of ophthalmic laser technologies, thereby contributing to the overall growth of the market in Europe.

Opportunities

The ophthalmic laser devices market is poised to benefit from several opportunities in the coming years. One prominent opportunity lies in the increasing investment in healthcare infrastructures, particularly in emerging economies. Governments and private stakeholders are actively enhancing their healthcare facilities, leading to greater access to advanced medical technologies, including ophthalmic lasers. As more healthcare providers adopt these technologies, the overall demand for ophthalmic laser devices is expected to rise. Additionally, the growing trend of telemedicine and remote patient monitoring opens avenues for increased awareness and accessibility to eye care, further enhancing market growth prospects.

Moreover, ongoing research and development efforts aimed at enhancing laser technologies present significant opportunities for innovation within the market. The introduction of new laser systems that offer improved precision, versatility, and safety profiles will likely attract more patients and healthcare providers alike. Collaborations between laser manufacturers and healthcare institutions are anticipated to yield novel solutions that address unmet clinical needs in ophthalmic care. As these advancements continue to unfold, the market for ophthalmic laser devices is expected to thrive, providing numerous avenues for established and emerging players alike.

Threats

While the ophthalmic laser devices market presents numerous growth opportunities, it also faces several threats that may hinder its progress. One significant concern is the high cost associated with acquiring and maintaining advanced ophthalmic laser systems, which can deter smaller clinics and healthcare facilities from investing in these technologies. Additionally, the rapid pace of technological advancements can lead to frequent updates and replacements, further increasing the financial burden on healthcare providers. This situation creates a competitive disadvantage for smaller players in the market, as they may struggle to keep up with larger institutions that can afford the latest innovations.

Another potential threat to the market is the stringent regulatory framework surrounding the approval and use of medical devices. Regulatory agencies require extensive clinical data and testing before granting approvals, which can delay the introduction of new ophthalmic laser technologies. This regulatory environment may stifle innovation and reduce the competitive edge for companies looking to launch new products in the market. Moreover, the potentially adverse effects associated with laser treatments, such as complications or patient dissatisfaction, can lead to increased scrutiny from regulatory bodies, complicating market dynamics.

Competitor Outlook

• Alcon Inc.
• Abbott Laboratories
• Bausch + Lomb
• Zeiss International
• Johnson & Johnson Vision
• Topcon Corporation
• Hoya Corporation
• Coherent Inc.
• Nidek Co., Ltd.
• Lumenis Ltd.
• IRIDEX Corporation
• Boston Scientific Corporation
• Abbott Medical Optics
• Asclepius Meditech Co., Ltd.
• Medtronic plc
• ORAYA Therapeutics, Inc.

The competitive landscape of the ophthalmic laser devices market is characterized by a mix of established players and emerging companies, each striving to capture a share of this rapidly evolving industry. Major companies like Alcon Inc. and Johnson & Johnson Vision have solidified their positions through continuous innovation, extensive research and development, and strategic partnerships. These companies leverage their strong brand recognition and expansive distribution networks to reach a wide audience. Additionally, they focus on developing advanced laser technologies that enhance surgical precision and improve patient outcomes, thereby maintaining a competitive edge in the market.

Furthermore, companies like Bausch + Lomb and Zeiss International are also playing a significant role in shaping the market by investing heavily in R&D to develop next-generation ophthalmic laser devices. Their commitment to innovation is evident in their product offerings, which include advanced technologies for refractive surgery, cataract surgery, and retinal treatments. Through collaborations and acquisitions, these companies are expanding their portfolios to include a diverse range of treatment options, further enhancing their market presence.

Emerging companies, such as IRIDEX Corporation and ORAYA Therapeutics, are also making significant strides in the ophthalmic laser devices market. These companies focus on niche products and specialized laser solutions, catering to specific patient needs and addressing unmet clinical demands. Their agility and adaptability allow them to respond quickly to market trends and capitalize on emerging opportunities. As they innovate and introduce unique solutions, they pose a competitive threat to established players, creating an increasingly dynamic market environment. Moreover, the ongoing advancements in laser technology, along with the increasing acceptance of laser-assisted surgeries, are expected to drive competition among both established and emerging companies in the coming years.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Alcon Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Lumenis Ltd.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Bausch + Lomb
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Coherent Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Medtronic plc
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Nidek Co., Ltd.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Hoya Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 IRIDEX Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Topcon Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Abbott Laboratories
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Zeiss International
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Abbott Medical Optics
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Johnson & Johnson Vision
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 ORAYA Therapeutics, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Asclepius Meditech Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis
  • 5.16 Boston Scientific Corporation
    • 5.16.1 Business Overview
    • 5.16.2 Products & Services
    • 5.16.3 Financials
    • 5.16.4 Recent Developments
    • 5.16.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Ophthalmic Laser Devices Sales Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Ophthalmic Clinics
    • 6.1.3 Ambulatory Surgical Centers
    • 6.1.4 Others
  • 6.2 Ophthalmic Laser Devices Sales Market, By Technology
    • 6.2.1 Photodisruption
    • 6.2.2 Photocoagulation
    • 6.2.3 Selective Laser Trabeculoplasty
    • 6.2.4 Photorefractive Keratectomy
    • 6.2.5 Others
  • 6.3 Ophthalmic Laser Devices Sales Market, By Application
    • 6.3.1 Refractive Error Correction
    • 6.3.2 Cataract Surgery
    • 6.3.3 Diabetic Retinopathy Treatment
    • 6.3.4 Glaucoma Treatment
    • 6.3.5 Others
  • 6.4 Ophthalmic Laser Devices Sales Market, By Product Type
    • 6.4.1 Excimer Lasers
    • 6.4.2 Femtosecond Lasers
    • 6.4.3 Nd:YAG Lasers
    • 6.4.4 Diode Lasers
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Ophthalmic Laser Devices Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Ophthalmic Laser Devices Sales market is categorized based on

By Product Type

• Excimer Lasers
• Femtosecond Lasers
• Nd:YAG Lasers
• Diode Lasers
• Others

By Application

• Refractive Error Correction
• Cataract Surgery
• Diabetic Retinopathy Treatment
• Glaucoma Treatment
• Others

By End User

• Hospitals
• Ophthalmic Clinics
• Ambulatory Surgical Centers
• Others

By Technology

• Photodisruption
• Photocoagulation
• Selective Laser Trabeculoplasty
• Photorefractive Keratectomy
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Alcon Inc.
• Abbott Laboratories
• Bausch + Lomb
• Zeiss International
• Johnson & Johnson Vision
• Topcon Corporation
• Hoya Corporation
• Coherent Inc.
• Nidek Co., Ltd.
• Lumenis Ltd.
• IRIDEX Corporation
• Boston Scientific Corporation
• Abbott Medical Optics
• Asclepius Meditech Co., Ltd.
• Medtronic plc
• ORAYA Therapeutics, Inc.